Aim: The aim of the study was to discover the metabolomic changes in plasma that occur
during human Ischemia-Reperfusion (I/R) injury and to evaluate the diagnostic utility of …

Acute myocardial infarction (MI) is one of the leading causes of death worldwide. Early
identification of ischemia and establishing reperfusion remain cornerstones in the treatment …

Myocardial infarction (MI) is a common and multifactorial disease that has the highest
morbidity and mortality in the world. Although a number of physiological, pathological, and …

Introduction Diagnosing myocardial infarction is difficult during the initial phase. As, acute
myocardial ischemia is associated with changes in metabolic pathways, metabolomics may …

Background—Recognition of myocardial ischemia is critical both for the diagnosis of
coronary artery disease and the selection and evaluation of therapy. Recent advances in …

Understanding the metabolic features of myocardial infarction (MI) is critical to its prevention
and treatment. Here, we aimed to characterize the metabolic features of early MI using a …

Despite recent advances in the diagnosis of myocardial ischemia, its biochemical
identification in patients with acute chest pain is still a challenge, and alternative approaches …

Objectives: The aim of this study was to investigate the metabolomic profile of acute
myocardial ischemia (MIS) using nuclear magnetic resonance spectroscopy of peripheral …

The elucidation of metabolic perturbations and gender-age-specific metabolic
characteristics associated with acute myocardial infarction (AMI) is essential for clinical risk …

Discovery of new biomarkers is critical for early diagnosis of acute coronary syndrome
(ACS). Recent advances in metabolomic technologies have drastically enhanced the …